T. E. Witzig

1.8k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

T. E. Witzig is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, T. E. Witzig has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in T. E. Witzig's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cell death mechanisms and regulation (2 papers). T. E. Witzig is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cell death mechanisms and regulation (2 papers). T. E. Witzig collaborates with scholars based in United States, Australia and Italy. T. E. Witzig's co-authors include Irene M. Ghobrial, Alex A. Adjei, Thomas M. Habermann, Steven M. Ansell, S. N. Markovic, Carrie A. Thompson, Kay M. Ristow, Ivana N. Micallef, Luis F. Porrata and David J. Inwards and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CA A Cancer Journal for Clinicians.

In The Last Decade

T. E. Witzig

12 papers receiving 1.5k citations

Hit Papers

Targeting Apoptosis Pathways in Cancer Therapy 2005 2026 2012 2019 2005 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting Apoptosis Pathways in Cancer Therapy
    2005 1.1k citations Irene M. Ghobrial, T. E. Witzig et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. E. Witzig United States 8 879 427 213 193 177 13 1.5k
Jana Jakubı́ková Slovakia 28 1.4k 1.6× 554 1.3× 164 0.8× 174 0.9× 224 1.3× 78 2.2k
Yurai Okaji Japan 21 910 1.0× 314 0.7× 201 0.9× 243 1.3× 248 1.4× 40 1.6k
Chengguang Zhao China 25 1.0k 1.1× 500 1.2× 187 0.9× 281 1.5× 157 0.9× 47 1.9k
Duncan H. Mak United States 33 1.6k 1.8× 428 1.0× 150 0.7× 223 1.2× 262 1.5× 88 2.5k
P. Benedetti Panici Italy 23 658 0.7× 496 1.2× 199 0.9× 158 0.8× 133 0.8× 53 1.7k
Sonia Emanuele Italy 25 1.0k 1.2× 298 0.7× 150 0.7× 321 1.7× 104 0.6× 51 1.8k
Claudia Ceci Italy 15 1.2k 1.3× 444 1.0× 185 0.9× 329 1.7× 225 1.3× 23 2.1k
Numsen Hail United States 29 1.6k 1.9× 385 0.9× 148 0.7× 326 1.7× 275 1.6× 41 2.4k
Tina S. Homayouni Canada 4 999 1.1× 430 1.0× 118 0.6× 223 1.2× 146 0.8× 4 1.9k
Radhamani Kannaiyan Singapore 9 858 1.0× 269 0.6× 188 0.9× 141 0.7× 112 0.6× 12 1.4k

Countries citing papers authored by T. E. Witzig

Since Specialization
Citations

This map shows the geographic impact of T. E. Witzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. E. Witzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. E. Witzig more than expected).

Fields of papers citing papers by T. E. Witzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. E. Witzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. E. Witzig. The network helps show where T. E. Witzig may publish in the future.

Co-authorship network of co-authors of T. E. Witzig

This figure shows the co-authorship network connecting the top 25 collaborators of T. E. Witzig. A scholar is included among the top collaborators of T. E. Witzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. E. Witzig. T. E. Witzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Porrata, Luis F., Kay M. Ristow, Joseph P. Colgan, et al.. (2011). Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica. 97(2). 262–269. 162 indexed citations
4.
Gertz, Morie A., Nelson Leung, M. Q. Lacy, et al.. (2009). Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney. Nephrology Dialysis Transplantation. 24(10). 3132–3137. 82 indexed citations
5.
Czuczman, M. S., Julie M. Vose, Pier Luigi Zinzani, et al.. (2009). Efficacy and safety of lenalidomide oral monotherapy in patients with relapsed or refractory diffuse large B-cell lymphoma: Results from an international study (NHL-003). Journal of Clinical Oncology. 27(15_suppl). e19504–e19504. 1 indexed citations
6.
Ansell, Stephen M. & T. E. Witzig. (2006). Antibody Therapy for Non-Hodgkin’s Lymphoma. Humana Press eBooks. 6(2). 445–455. 1 indexed citations
7.
Ghobrial, Irene M., T. E. Witzig, & Alex A. Adjei. (2005). Targeting Apoptosis Pathways in Cancer Therapy. CA A Cancer Journal for Clinicians. 55(3). 178–194. 1148 indexed citations breakdown →
8.
Czuczman, M. S., T. E. Witzig, Leo I. Gordon, et al.. (2004). Low incidence of treatment-related myelodysplastic syndrome (tMDS) and acute myelogenous leukemia (tAML) in patients with non-Hodgkin's lymphoma (NHL) treated with ibritumomab tiuxetan. Journal of Clinical Oncology. 22(14_suppl). 6696–6696. 1 indexed citations
9.
Witzig, T. E.. (2003). Promising preclinical activity of 2‐methoxyestradiol in multiple myeloma. European Journal Of Haematology. 70(4). 268–268. 12 indexed citations
10.
Witzig, T. E., Michael Timm, Mary Stenson, Phyllis A. Svingen, & Scott H. Kaufmann. (2000). Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.. PubMed. 6(2). 681–92. 43 indexed citations
11.
Wiseman, Gregory A., Leo I. Gordon, T. E. Witzig, et al.. (2000). Zevalin radioimmunotherapy is not associated with significant or prolonged depletion of t cells or natural killer cells. 96. 3 indexed citations
12.
Patel, Tushar, S. Breanndan Moore, Alvaro A. Pineda, & T. E. Witzig. (1996). Role of Plasmapheresis in Thrombocytopenic Purpura Associated With Waldenström's Macroglobulinemia. Mayo Clinic Proceedings. 71(6). 597–600. 12 indexed citations
13.
Witzig, T. E., Nick J. Gonchoroff, Terry M. Therneau, et al.. (1991). DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication. Cancer. 68(8). 1781–1788. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jana Jakubı́ková Breakdown of academic impact, for papers by Yurai Okaji Breakdown of academic impact, for papers by Chengguang Zhao Breakdown of academic impact, for papers by Duncan H. Mak Breakdown of academic impact, for papers by P. Benedetti Panici Breakdown of academic impact, for papers by Sonia Emanuele Breakdown of academic impact, for papers by Claudia Ceci Breakdown of academic impact, for papers by Numsen Hail Breakdown of academic impact, for papers by Tina S. Homayouni Breakdown of academic impact, for papers by Radhamani Kannaiyan
Rankless by CCL
2026